MarketCapTrends
XBIO
Xenetic Biosciences Inc. (XBIO)
NASDAQ · Healthcare

Xenetic Biosciences Inc. Total Liabilities 2012–2025

Xenetic Biosciences Inc. annual/quarterly total liabilities history from 2012 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.

  • Xenetic Biosciences Inc. total liabilities for the quarter ending December 31, 2025 were 968,025, a 8.25% increase year-over-year.
  • Xenetic Biosciences Inc. total liabilities for 2025 were 968,025, a 8.25% increase from 2024.
  • Xenetic Biosciences Inc. total liabilities for 2024 were 894,263, a 10.46% increase from 2023.
  • Xenetic Biosciences Inc. total liabilities for 2023 were 809,585, a 24.56% decrease from 2022.
  • Xenetic Biosciences Inc. total liabilities for 2022 were 1.1M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
Xenetic Biosciences Inc. Annual Total Liabilities (Millions of US $)
2025$1
2024$1
2023$1
2022$1
2021$1
2020$1
2019$4
2018$5
2017$5
2016$5
2015$10
2014$6
2013$7
2012$5
Xenetic Biosciences Inc. Quarterly Total Liabilities (Millions of US $)
2025-12-31$1
2024-12-31$1
2023-12-31$1
2022-12-31$1
2021-12-31$1
2020-12-31$1
2019-12-31$4
2018-12-31$5
2017-12-31$5
2016-12-31$5
2015-12-31$10
2014-12-31$6
2013-12-31$7
2013-08-31$1
2012-12-31$5
2012-08-31$0

Xenetic Biosciences Inc. Total Liabilities — FAQ

Xenetic Biosciences Inc. (XBIO) total liabilities over the last 16 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see XBIO's total liabilities history?

The chart and table above show Xenetic Biosciences Inc.'s total liabilities by year and by quarter, including the growth rate.